Volume 96, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



infection is a persistent threat in resource-restricted settings in southeast Asia but informative data about this disease remain limited. We analyzed characteristics, management, and predictors of outcome in severely septic patients with community-onset infection in northeast Thailand. We performed a prospective, multicenter observational cohort study of community-onset sepsis in four referral hospitals recruiting patients at least 14 years of age admitted between March 2010 and December 2013. One hundred and nineteen patients with severe staphylococcal sepsis were enrolled. Diabetes was the most common underlying condition. Methicillin-resistant infection was rare. Twenty-eight-day mortality was 20%. Ninety-two percent of patients received appropriate antibiotic therapy and 82% were administered intravenous fluids on the first hospital day, although only 14% were managed in an intensive care unit (ICU). On univariable analysis, clinical variables at enrollment significantly associated with death at 28 days were coagulopathy or respiratory failure. Plasma interleukin (IL)-8 concentration alone accurately predicted mortality (area under the receiver operating curve = 0.82, 95% confidence interval = 0.73–0.90). In multivariable analysis, addition of IL-8 concentration to a mortality prediction model containing clinical variables further improved the predictive ability of the model. We conclude that severe staphylococcal sepsis in northeast Thailand causes significant mortality. Diabetes is a common preexisting condition and most patients are managed outside the ICU even if they receive vasoactive/inotropic agents or mechanical ventilation. While clinical factors apparent on presentation including coagulopathy and respiratory failure predict death, plasma IL-8 improves this prediction.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Nickerson EK, West TE, Day NP, Peacock SJ, , 2009. Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. Lancet Infect Dis 9: 130135.[Crossref] [Google Scholar]
  2. Vlieghe ER, Phe T, De Smet B, Veng HC, Kham C, Lim K, Koole O, Lynen L, Peetermans WE, Jacobs JA, , 2013. Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns. PLoS One 8: e59775.[Crossref] [Google Scholar]
  3. Stoesser N, Moore CE, Pocock JM, An KP, Emary K, Carter M, Sona S, Poda S, Day N, Kumar V, Parry CM, , 2013. Pediatric bloodstream infections in Cambodia, 2007 to 2011. Pediatr Infect Dis J 32: e272e276.[Crossref] [Google Scholar]
  4. Anderson M, Luangxay K, Sisouk K, Vorlasan L, Soumphonphakdy B, Sengmouang V, Chansamouth V, Phommasone K, Van Dyke R, Chong E, Dance DA, Phetsouvanh R, Newton PN, , 2014. Epidemiology of bacteremia in young hospitalized infants in Vientiane, Laos, 2000–2011. J Trop Pediatr 60: 1016.[Crossref] [Google Scholar]
  5. Martin GS, Mannino DM, Eaton S, Moss M, , 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 15461554.[Crossref] [Google Scholar]
  6. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K, , 2015. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations. Am J Respir Crit Care Med 193: 259272.[Crossref] [Google Scholar]
  7. Ferry T, Perpoint T, Vandenesch F, Etienne J, , 2005. Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes. Curr Infect Dis Rep 7: 420428.[Crossref] [Google Scholar]
  8. Lowy FD, , 1998. Staphylococcus aureus infections. N Engl J Med 339: 520532.[Crossref] [Google Scholar]
  9. Cheng AC, West TE, Limmathurotsakul D, Peacock SJ, , 2008. Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 5: e175.[Crossref] [Google Scholar]
  10. Jacob ST, Lim M, Banura P, Bhagwanjee S, Bion J, Cheng AC, Cohen H, Farrar J, Gove S, Hopewell P, Moore CC, Roth C, West TE, , 2013. Integrating sepsis management recommendations into clinical care guidelines for district hospitals in resource-limited settings: the necessity to augment new guidelines with future research. BMC Med 11: 107.[Crossref] [Google Scholar]
  11. Nickerson EK, Wuthiekanun V, Day NP, Chaowagul W, Peacock SJ, , 2006. Methicillin-resistant Staphylococcus aureus in rural Asia. Lancet Infect Dis 6: 7071.[Crossref] [Google Scholar]
  12. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D, , 2013. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 8: e54714.[Crossref] [Google Scholar]
  13. Nickerson EK, Wuthiekanun V, Wongsuvan G, Limmathurosakul D, Srisamang P, Mahavanakul W, Thaipadungpanit J, Shah KR, Arayawichanont A, Amornchai P, Thanwisai A, Day NP, Peacock SJ, , 2009. Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country. PLoS One 4: e6512.[Crossref] [Google Scholar]
  14. Chantratita N, Wikraiphat C, Tandhavanant S, Wongsuvan G, Ariyaprasert P, Suntornsut P, Thaipadungpanit J, Teerawattanasook N, Jutrakul Y, Srisurat N, Chaimanee P, Anukunananchai J, Phiphitaporn S, Srisamang P, Chetchotisakd P, West TE, Peacock SJ, , 2016. Comparison of community-onset Staphylococcus argenteus and Staphylococcus aureus sepsis in Thailand: a prospective multicentre observational study. Clin Microbiol Infect 22: 458.[Crossref] [Google Scholar]
  15. Bone RC, Sibbald WJ, Sprung CL, , 1992. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101: 14811483.[Crossref] [Google Scholar]
  16. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL, , 2001. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286: 17541758.[Crossref] [Google Scholar]
  17. Pierrakos C, Vincent JL, , 2010. Sepsis biomarkers: a review. Crit Care 14: R15.[Crossref] [Google Scholar]
  18. Mahavanakul W, Nickerson EK, Srisomang P, Teparrukkul P, Lorvinitnun P, Wongyingsinn M, Chierakul W, Hongsuwan M, West TE, Day NP, Limmathurotsakul D, Peacock SJ, , 2012. Feasibility of modified surviving sepsis campaign guidelines in a resource-restricted setting based on a cohort study of severe S. aureus sepsis. PLoS One 7: e29858.[Crossref] [Google Scholar]
  19. Aekplakorn W, Abbott-Klafter J, Premgamone A, Dhanamun B, Chaikittiporn C, Chongsuvivatwong V, Suwanprapisa T, Chaipornsupaisan W, Tiptaradol S, Lim SS, , 2007. Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004. Diabetes Care 30: 20072012.[Crossref] [Google Scholar]
  20. Smit J, Sogaard M, Schonheyder HC, Nielsen H, Froslev T, Thomsen RW, , 2016. Diabetes and risk of community-acquired Staphylococcus aureus bacteremia: a population-based case-control study. Eur J Endocrinol 174: 631639.[Crossref] [Google Scholar]
  21. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, Filbin MR, Shapiro NI, Angus DC, , 2014. A randomized trial of protocol-based care for early septic shock. N Engl J Med 370: 16831693.[Crossref] [Google Scholar]
  22. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Tan JC, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM, , 2015. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock. Health Technol Assess 19: 1150.[Crossref] [Google Scholar]
  23. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P, , 2014. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371: 14961506.[Crossref] [Google Scholar]
  24. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA, , 1992. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60: 28352842. [Google Scholar]
  25. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM, , 1994. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 22: 673679.[Crossref] [Google Scholar]
  26. Feuerstein G, Rabinovici R, , 1994. Importance of interleukin-8and chemokines in organ injury and shock. Crit Care Med 22: 550551.[Crossref] [Google Scholar]
  27. Fujishima S, Sasaki J, Shinozawa Y, Takuma K, Kimura H, Suzuki M, Kanazawa M, Hori S, Aikawa N, , 1996. Serum MIP-1 alpha and IL-8 in septic patients. Intensive Care Med 22: 11691175.[Crossref] [Google Scholar]
  28. Wong HR, Cvijanovich N, Wheeler DS, Bigham MT, Monaco M, Odoms K, Macias WL, Williams MD, , 2008. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 178: 276282.[Crossref] [Google Scholar]
  29. Calfee CS, Thompson BT, Parsons PE, Ware LB, Matthay MA, Wong HR, , 2010. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Crit Care Med 38: 14361441.[Crossref] [Google Scholar]
  30. Blackwell TS, Christman JW, , 1996. Sepsis and cytokines: current status. Br J Anaesth 77: 110117.[Crossref] [Google Scholar]
  31. Casey LC, Balk RA, Bone RC, , 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771778.[Crossref] [Google Scholar]
  32. Endo S, Inada K, Inoue Y, Kuwata Y, Suzuki M, Yamashita H, Hoshi S, Yoshida M, , 1992. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock 38: 264274. [Google Scholar]
  33. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC, , 1995. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 274: 172177.[Crossref] [Google Scholar]
  34. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, , 2013. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 41: 580637.[Crossref] [Google Scholar]

Data & Media loading...

Supplemental Table

  • Received : 25 Jul 2016
  • Accepted : 29 Dec 2016
  • Published online : 06 Feb 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error